Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV
about
No evidence for XMRV in German CFS and MS patients with fatigue despite the ability of the virus to infect human blood cells in vitroThe mouse "xenotropic" gammaretroviruses and their XPR1 receptorXMRV and prostate cancer--a 'final' perspectiveCrystal structure of xenotropic murine leukaemia virus-related virus (XMRV) ribonuclease HCharacterization, mapping, and distribution of the two XMRV parental provirusesEvidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndromeStudies on the restriction of murine leukemia viruses by mouse APOBEC3Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1Xenotropic MLV envelope proteins induce tumor cells to secrete factors that promote the formation of immature blood vessels.The saga of XMRV: a virus that infects human cells but is not a human virus.No detection of XMRV in blood samples and tissue sections from prostate cancer patients in Northern EuropeAbsence of XMRV in peripheral blood mononuclear cells of ARV-treatment naïve HIV-1 infected and HIV-1/HCV coinfected individuals and blood donors.Identification of XMRV infection-associated microRNAs in four cell types in culture.Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.Recombinant origin, contamination, and de-discovery of XMRVXMRV induces cell migration, cytokine expression and tumor angiogenesis: are 22Rv1 cells a suitable prostate cancer model?Human APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity.Utilization of replication-competent XMRV reporter-viruses reveals severe viral restriction in primary human cells.Severe restriction of xenotropic murine leukemia virus-related virus replication and spread in cultured human peripheral blood mononuclear cells.In vivo hypermutation of xenotropic murine leukemia virus-related virus DNA in peripheral blood mononuclear cells of rhesus macaque by APOBEC3 proteinsPhylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis/chronic fatigue syndrome and prostate cancerMurine leukemia viruses: objects and organisms.XMRV Discovery and Prostate Cancer-Related Research.Recombinant origin of the retrovirus XMRV.Human and murine APOBEC3s restrict replication of koala retrovirus by different mechanisms.Moloney murine leukemia virus glyco-gag facilitates xenotropic murine leukemia virus-related virus replication through human APOBEC3-independent mechanismsGenome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens.Origin of XMRV and its demise as a human pathogen associated with chronic fatigue syndromeDownregulation of APOBEC3G by xenotropic murine leukemia-virus related virus (XMRV) in prostate cancer cells.Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases.
P2860
Q21135591-C4DFC56C-B99F-4ABA-B767-7C4E65A94571Q24622259-55254C54-345B-4A3D-A9E8-F2D5DBD5B572Q27010480-D44F4FA2-8F89-4F9A-9C11-76AC551E34EBQ27681320-548FBAD9-9595-4BA3-90B6-FB4654FCFFB8Q28251595-E63D8A9C-36B8-4A77-BCEA-FA47CDA807F8Q28304673-56A44F48-61B1-4AA5-9CBC-B5B24C27383AQ28729128-EAD330E0-0A74-4FA9-AC03-A0E8975C06A9Q28729913-22D3708E-E07E-46B0-9E5F-DC7DFA3DD13EQ30418789-6E76D02D-9509-4AB2-9DC9-F632BD8380B1Q33561230-D3A16DD1-6CF5-4B96-A136-2CAD29CE891BQ34055653-C326CB32-B2D6-485B-9AEF-7A74D72F0321Q34163532-F2E36A32-903A-4547-BE3F-017E959C22EAQ34206105-C01DFF65-B23E-4852-A0DA-43B8D11804CFQ34278035-CA2756CC-B423-4EB7-86C2-9A3691DABAE6Q34289436-2B0BE5DE-AB5C-44B9-9F9E-D8AE61373CF0Q34359717-BDA50BB6-6C1A-4375-80AD-4E65BF45FDD0Q34558286-893A5E43-735E-485A-BD97-4EEE5155959DQ34994674-2AF6E24E-C718-4AE1-A351-9E5D3637E5F4Q35076674-C21F95B5-4901-45AC-8E3D-1CC2D52204BAQ35529276-BE25F540-EAFF-4E0B-B55B-924FDB48FC8AQ35692325-819A9E98-E019-43F2-8200-2DAA4C7FEA38Q35692330-E88C79B9-1AC5-4BF7-A880-84F59BEB240DQ35692335-4C9213DE-55E2-456D-B535-072B69F359E5Q35755248-D8A6DAD5-4902-46D3-A5B8-6129590D3E0AQ35927461-647AB1DB-4DB4-4462-B118-C0EF62018607Q36175682-C68DDA9C-1A54-46E2-8E9F-F06D39C06DB3Q36859140-6BB5C953-C3EE-4538-8E55-663D50E140B6Q38326994-EC842011-E061-479B-B9C6-BAA1E6197981Q38616294-C5925040-634B-4DB6-A7A5-834C553A4CDBQ39431501-BD0DB79D-024C-405D-B661-2FF2624FE94FQ39595254-C6AD016E-2B10-40C5-927F-8819341A2E1A
P2860
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV
@ast
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV
@en
type
label
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV
@ast
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV
@en
prefLabel
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV
@ast
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV
@en
P2860
P1433
P1476
Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRV
@en
P2093
Kristin Stieler
Nicole Fischer
P2860
P304
P356
10.1371/JOURNAL.PONE.0011738
P407
P577
2010-07-23T00:00:00Z